Ben Trotman, diagnosed with terminal glioblastoma in 2022, experienced a complete remission after receiving ipilimumab before standard treatment as pa ...

As Branden Newman undergoes daily treatment, the couple draws strength from their faith and a community that has rallied ...

Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.

University of Kentucky Markey Cancer Center researchers have discovered a genetic biomarker that could help identify patients ...

In a devastating turn of event, 40-year-old Ben Trotman was being diagnosed with the deadlist form of brain cancer in 2022, ...

Man with deadly glioblastoma shows no signs of disease after taking experimental immunotherapy drug ipilimumab, inspiring a ...

A man with one of the deadliest forms of brain cancer is now hopeful for the future after his tumor completely disappeared ...

A UCL-sponsored clinical trial for patients newly diagnosed with glioblastoma, an aggressive form of brain cancer, has opened ...

From dietary patterns to side effects of common medications, know how glioblastoma can develop in young adults.

Researchers at the University of Kentucky’s Markey Cancer Center report they have discovered a genetic biomarker that could ...

In July 2025, Inovio Pharmaceuticals conducted a Phase 1/2 trial to evaluate safety, immunogenicity and preliminary efficacy of INO-5401 and INO-9012 in combination with cemiplimab (REGN2810), with ...